New Scientist on MSN4h
Vaccine misinformation can easily poison AI – but there's a fix
Adding just a little medical misinformation to an AI model’s training data increases the chances that chatbots will spew ...
Fact Check: Edited BioNTech CEO clip resurfaces with false vaccine claim
The CEO of BioNTech Ugur Sahin was inoculated in early 2021 with the COVID-19 vaccine his team developed with Pfizer, a ...
Vaccine Stocks Jump on U.S. Bird-Flu Death
Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first ...
Scientists Are Racing to Develop a New Bird Flu Vaccine
A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.
Federal judge rejects 'inaccurate' characterization of COVID vaccine decision
A federal judge last month refused to alter her decision dismissing a sprawling lawsuit that claimed a COVID-19 vaccination ...
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...
Nick Rolovich loses lawsuit vs. WSU after being fired for refusing COVID vaccine
Former WSU football coach Nick Rolovich lost his lawsuit against the university that stemmed from his firing for refusing to ...
Is there a vaccine that can prevent HMPV infection?
In India, 7 cases of the Human metapneumovirus (hMPV) have been reported. This virus mainly affects young children, the ...
Ebola: How a vaccine turned a terrifying virus into a preventable disease
The Ebola virus devastated west Africa in 2014, claiming over 11,000 lives in Sierra Leone, Liberia and Guinea.
WuXi Bio to Sell Vaccine Facility to Merck for $500 Million
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...
KGUN 910h
Norovirus vaccine trial underway in Tucson as cases surge nationwide
The Quality of Life Research Center in Tucson looking for participants 70 years old and up to take part in a clinical trial to test a potential norovirus vaccine ...